Abstract Purpose of Review With the advent of highly active antiretroviral therapy (ART), the
life span of persons with HIV (PWH) has been nearly normalized. With aging, prevalence of …

Cardiovascular toxicity of contemporary antiretroviral thera... : Current Opinion in HIV and AIDS
Cardiovascular toxicity of contemporary antiretroviral therapy : Current Opinion in HIV and …

Metabolic syndrome (MetS) is a constellation of factors including hypertension, abdominal
obesity, dyslipidemia, and insulin resistance that separately and together significantly …

Background: HIV infection results in immunometabolic reprogramming. While we are
beginning to understand how this metabolic reprogramming regulates the immune response …

The introduction of antiretroviral therapy (ART) has caused some metabolic problems to
people who suffer from HIV. ART probably is not the sole reason for these metabolic …

Metabolic syndrome (MetS) elevates the risk of heart disease and stroke. In recent decades,
the escalating prevalence of MetS among people living with HIV/AIDS (PLWHA) has …

While human immunodeficiency virus (HIV)-associated wasting has declined with significant
advances in antiretroviral therapy (ART), weight gain and metabolic syndrome (MetS) are …

The role of cardiometabolic diseases (CMDs) on physical health–related quality of life (P-
HRQoL) and quality of sleep was examined among 261 PLWH≥ 40 years, recruited from a …

Background Cardiometabolic outcomes were investigated 3 years after switching to the 2-
drug regimen dolutegravir/lamivudine (DTG/3TC) vs continuing 3-/4-drug tenofovir …

Background Brain-derived neurotrophic factor (BDNF) has been implicated in the
development of cardiometabolic risk factors in some populations. However, few studies have …